Table 1 Demographic and polysomnographic characteristics (n = 410).
From: Utilization of the GOAL questionnaire as a standardized screening tool for obstructive sleep apnea
Parameter | Total number of patients (n = 410) | Simple snoring group (n = 89) | OSA group (n = 321) | P-value |
|---|---|---|---|---|
Male (n [%])a | 298 (72.7) | 41 (46.07) | 257 (80.06) | < 0.001* |
Age (year)b | 45.59 ± 14.30 | 39.7 ± 14.12 | 47.54 ± 13.69 | 0.001* |
BMI (kg/m2)b | 27.91 ± 4.47 | 24.9 ± 4.07 | 28.70 ± 4.25 | < 0.001* |
NC (cm)b | 38.97 ± 4.12 | 35.44 ± 3.04 | 39.90 ± 3.89 | < 0.001* |
Hypertension (n [%])a | 207 (50.5) | 24 (26.97) | 183 (57.01) | < 0.001* |
Diabetes (n [%])a | 108 (26.3) | 12 (13.5) | 96 (29.9) | 0.002* |
Coronary disease (n [%])a | 52 (12.7) | 9 (10.1) | 43 (13.4) | 0.278 |
CVD (n [%])a | 20 (4.9) | 4 (4.5) | 16 (5.0) | 0.849 |
Loud snoring (n [%])a | 347 (84.6) | 32 (35.96) | 315 (98.13) | < 0.001* |
Observed apnea (n [%])a | 200 (48.7) | 7 (7.87) | 193 (60.12) | < 0.001* |
Tiredness (n [%])a | 228 (55.6) | 20 (22.47) | 208 (64.80) | < 0.001* |
No-Apnea(points)b | 3.75 ± 2.29 | 1.61 ± 1.43 | 4.35 ± 2.13 | < 0.001* |
STOP-Bang(points)b | 4.04 ± 1.77 | 1.80 ± 1.05 | 4.70 ± 1.38 | < 0.001* |
NoSAS (points)b | 8.90 ± 4.13 | 3.99 ± 2.69 | 10.27 ± 3.44 | < 0.001* |
GOAL (points)b | 2.25 ± 0.88 | 1.21 ± 0.66 | 2.56 ± 0.71 | < 0.001* |
ADA (s)b | 23.01 ± 8.07 | 17.31 ± 8.80 | 24.50 ± 6.84 | < 0.001* |
MDA (s)b | 51.36 ± 22.84 | 29.04 ± 22.87 | 57.61 ± 18.57 | < 0.001* |
ODI (n/h)b | 30.34 ± 25.58 | 4.04 ± 3.41 | 37.35 ± 23.78 | < 0.001* |
NMSBP (mmHg)b | 174.99 ± 31.72 | 156.52 ± 20.74 | 180.74 ± 32.00 | < 0.001* |
NMDBP (mmHg)b | 94.25 ± 12.69 | 88.31 ± 8.443 | 96.04 ± 13.20 | < 0.001* |
AHI (events/h)b | 32.30 ± 27.63 | 2.69 ± 1.14 | 40.69 ± 25.83 | < 0.001* |
Mean SpO2 (%)b | 91.93 ± 4.65 | 94.36 ± 3.83 | 91.43 ± 4.42 | < 0.001* |
Minimum SpO2 (%)b | 77.44 ± 11.93 | 86.79 ± 8.49 | 75.11 ± 11.29 | < 0.001* |